Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...

Professor Joanna Moncrieff’s new book Chemically Unbalanced further calls for greater patient consent provisions to inform ...

Amitriptyline has long been used for migraine prevention. Discover how this antidepressant works, its side effects, and why it's still being prescribed.

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

In the logistic regression model of the top 20 factors, significant associations for semaglutide initiation included being female (adjusted odds ratio, 2.30), using certain medication classes ...

Government plans to create ‘neighbourhood health centres’ as Dr Simon Opher proposes drafting psychologists into practices ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression ...

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

Preventing or treating infections could be a key means of warding off dementia, a new evidence review says.Vaccines, ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

The U.S. Food and Drug Administration has approved a nasal spray that is known to help treat depression.